The changes Michigan’s Department of Licensing and Regulatory Affairs have proposed for opioid clinic regulation threaten to hamper the ability of clinics to operate within the state.
“Remission [must be] a component of a broader change in behavior, outlook and identity,” concludes the Surgeon General’s report. “That change process becomes an ongoing part of how they think about themselves and their experience with substances.”
Like many firms in legal jeopardy, the drug distributor AmerisourceBergen, facing a massive number of opioid-related lawsuits, has upped donations through its foundation. Whether this will stem the legal tide remains to be seen.
With settlement talks looming, drug companies connected with the opioid industry are making unusually generous and frequent donations to nonprofits in regions where they are being sued.
A new twist emerges in a Massachusetts case filed last week against Purdue Pharma for its role in the nation’s opioid epidemic. Piercing the corporate veil, the state attorney general’s office names eight executives and eight Sackler family board members as individual defendants.
In 1998, a tobacco settlement produced $246 billion for state governments but not a cent for American Indian nations. With hundreds of opioid-related lawsuits now in front of a Cleveland-based federal judge, American Indian nations are determined not to be left out this time.
Congress has called for accountability from drug manufacturers and wants federal agencies to call for fair pricing.
Pill dumping in West Virginia on a massive scale raises a host of questions regarding what would appear to be grossly negligent oversight by many of the nation’s leading pharmaceutical distributors.
Incubators in Silicon Valley and other high-tech, startup-heavy areas are common. Less common are incubators in struggling areas like Stowe and McKees Rocks, two struggling suburbs of Pittsburgh. That, however, is the space where Launch Sto-Rox is operating in the hopes of revitalizing the communities.
Cities and states provide legislative, but not necessarily financial, support for new harm reduction strategies to combat opioid epidemic.
